Máté Vámos

1.4k total citations
81 papers, 906 citations indexed

About

Máté Vámos is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Máté Vámos has authored 81 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Máté Vámos's work include Cardiac pacing and defibrillation studies (45 papers), Cardiac Arrhythmias and Treatments (39 papers) and Cardiac electrophysiology and arrhythmias (29 papers). Máté Vámos is often cited by papers focused on Cardiac pacing and defibrillation studies (45 papers), Cardiac Arrhythmias and Treatments (39 papers) and Cardiac electrophysiology and arrhythmias (29 papers). Máté Vámos collaborates with scholars based in Hungary, Germany and United States. Máté Vámos's co-authors include Stefan H. Hohnloser, Julia W. Erath, Gábor Zoltán Duray, Alexander P. Benz, Renato D. Lópes, Géza Szita, Margit Kulcsár, Sz. Jánosi, Mariann Fodor and G. Huszenicza and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and European Heart Journal.

In The Last Decade

Máté Vámos

63 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Máté Vámos Hungary 16 685 129 104 59 51 81 906
Laurent Meyer France 18 152 0.2× 301 2.3× 73 0.7× 215 3.6× 51 1.0× 51 929
Ahmed Bennis Morocco 11 235 0.3× 81 0.6× 8 0.1× 17 0.3× 89 1.7× 41 453
N. R. H. El-Maraghi Canada 6 147 0.2× 92 0.7× 10 0.1× 67 1.1× 31 0.6× 10 361
Qianchuan Huang China 6 73 0.1× 23 0.2× 42 0.4× 11 0.2× 88 1.7× 14 818
Daniel R. Lexcen United States 15 341 0.5× 115 0.9× 2 0.0× 30 0.5× 152 3.0× 41 570
Casey E. Dunne United States 10 64 0.1× 193 1.5× 12 0.1× 4 0.1× 96 1.9× 13 517
M. Gander Switzerland 14 330 0.5× 188 1.5× 14 0.1× 9 0.2× 26 0.5× 45 540
Josef Widerhorn United States 8 274 0.4× 98 0.8× 4 0.0× 5 0.1× 43 0.8× 9 480
Kyle Widmer United States 7 68 0.1× 55 0.4× 12 0.1× 6 0.1× 393 7.7× 9 495
Oya Eralp Türkiye 10 31 0.0× 52 0.4× 6 0.1× 37 0.6× 64 1.3× 11 376

Countries citing papers authored by Máté Vámos

Since Specialization
Citations

This map shows the geographic impact of Máté Vámos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Máté Vámos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Máté Vámos more than expected).

Fields of papers citing papers by Máté Vámos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Máté Vámos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Máté Vámos. The network helps show where Máté Vámos may publish in the future.

Co-authorship network of co-authors of Máté Vámos

This figure shows the co-authorship network connecting the top 25 collaborators of Máté Vámos. A scholar is included among the top collaborators of Máté Vámos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Máté Vámos. Máté Vámos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Török, G., Dávid Pilecky, Máté Vámos, et al.. (2024). The development and long-term maintenance of heart failure with improved ejection fraction after a heart failure hospitalization: how are mortality rates affected?. European Heart Journal. 45(Supplement_1). 1 indexed citations
3.
Wakili, Reza, Előd János Zsigmond, László Sághy, et al.. (2024). Risk of Cardiac Implantable Electronic Device Infection after Early versus Delayed Lead Repositioning. Journal of Cardiovascular Development and Disease. 11(4). 117–117. 1 indexed citations
4.
Pilecky, Dávid, Máté Vámos, Péter Andréka, et al.. (2024). The effect of kidney function on guideline‐directed medical therapy implementation and prognosis in heart failure with reduced ejection fraction. Clinical Cardiology. 47(2). e24244–e24244. 5 indexed citations
5.
Nemes, Attila, et al.. (2024). Az orális antikoagulánsok alkalmazásának 10 éves trendjei pitvarfibrilláció miatt katéterablációra kerülő betegeknél. SHILAP Revista de lepidopterología. 54(2). 92–99.
6.
Pilecky, Dávid, et al.. (2024). Therapeutic Consequences and Prognostic Impact of Multimorbidity in Heart Failure: Time to Act. Journal of Clinical Medicine. 14(1). 139–139. 2 indexed citations
7.
Pilecky, Dávid, Máté Vámos, Előd Papp, et al.. (2024). The impact of comorbidities on therapy-optimization and their prognostics role among hospitalized patients with heart failure with reduced ejection fraction. European Heart Journal. 45(Supplement_1).
8.
Pap, Róbert, et al.. (2023). Use of mexiletine in therapy-refractory recurrent ventricular tachycardia storm. Herzschrittmachertherapie + Elektrophysiologie. 34(4). 326–329.
9.
Tokodi, Márton, Attila Kovács, István Osztheimer, et al.. (2023). Phenogrouping and risk stratification of patients undergoing cardiac resynchronization therapy upgrade using topological data analysis. Scientific Reports. 13(1). 20594–20594. 3 indexed citations
10.
El‐Battrawy, Ibrahim, Julia W. Erath, Máté Vámos, et al.. (2022). A Case Series of Concomitant Cardiac Electrical Disease among Takotsubo Syndrome Patients and Literature Review. Journal of Cardiovascular Development and Disease. 9(3). 79–79. 2 indexed citations
11.
Kattih, Badder, et al.. (2022). Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort. Frontiers in Cardiovascular Medicine. 9. 1008311–1008311. 3 indexed citations
12.
Vámos, Máté, Lidia Haţegan, Lilla Hanák, et al.. (2022). Geno- and phenotypic characteristics and clinical outcomes of CACNA1C gene mutation associated Timothy syndrome, “cardiac only” Timothy syndrome and isolated long QT syndrome 8: A systematic review. Frontiers in Cardiovascular Medicine. 9. 1021009–1021009. 5 indexed citations
13.
14.
Vámos, Máté, et al.. (2019). Association of Remote Monitoring With Survival in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy: Retrospective Observational Study. Journal of Medical Internet Research. 21(7). e14142–e14142. 12 indexed citations
15.
Kosztin, Annamária, Máté Vámos, Dániel Aradi, et al.. (2017). De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis. Heart Failure Reviews. 23(1). 15–26. 34 indexed citations
16.
Vámos, Máté, Jeff S. Healey, Jia Wang, et al.. (2017). Implantable cardioverter–defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy. Heart Rhythm. 15(3). 386–392. 9 indexed citations
17.
Vámos, Máté, Jörg Honold, Gábor Zoltán Duray, & Stefan H. Hohnloser. (2016). MICRA Leadless Pacemaker on Autopsy. JACC. Clinical electrophysiology. 2(5). 636–637. 26 indexed citations
18.
Erath, Julia W., Máté Vámos, & Stefan H. Hohnloser. (2016). Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patients. European Heart Journal - Cardiovascular Pharmacotherapy. 2(3). 168–174. 13 indexed citations
19.
Erath, Julia W., et al.. (2016). The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients. Clinical Research in Cardiology. 106(4). 300–306. 31 indexed citations
20.
Vámos, Máté, Jeff S. Healey, Jia Wang, et al.. (2015). Troponin levels after ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial. Heart Rhythm. 13(2). 504–510. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurent Meyer Breakdown of academic impact, for papers by Ahmed Bennis Breakdown of academic impact, for papers by N. R. H. El-Maraghi Breakdown of academic impact, for papers by Qianchuan Huang Breakdown of academic impact, for papers by Daniel R. Lexcen Breakdown of academic impact, for papers by Casey E. Dunne Breakdown of academic impact, for papers by M. Gander Breakdown of academic impact, for papers by Josef Widerhorn Breakdown of academic impact, for papers by Kyle Widmer Breakdown of academic impact, for papers by Oya Eralp
Rankless by CCL
2026